In terms of mechanism, AURKA inhibits DNA damage responses in a TP53-dependent manner by inhibiting the expression of multiple DNA damage repair genes, which may partly explain ARUKA’s association with beneficial outcomes in colon cancer. Here, TP53 is linked to colonic neoplasm.